Morgan Stanley Foghorn Therapeutics Inc. Transaction History

Morgan Stanley

$1.59 Trillion
Q3 2025

A detailed history of Morgan Stanley transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Morgan Stanley holds 63,676 shares of FHTX stock, worth $298,640. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,676

Previous 79,553 19.96%

Holding current value

$298,640

Previous $373,000 16.62%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$4.58 - $6.5 $72,716 - $103,200	-15,877 Reduced 19.96%	63,676 $311,000
Q2 2025 Aug 15, 2025	BUY	$3.15 - $4.9 $31,758 - $49,401	10,082 Added 14.51%	79,553 $373,000
Q1 2025 May 15, 2025	SELL	$3.52 - $6.16 $98,820 - $172,935	-28,074 Reduced 28.78%	69,471 $253,000
Q4 2024 Feb 14, 2025	SELL	$4.61 - $9.35 $49,124 - $99,633	-10,656 Reduced 9.85%	97,545 $460,000
Q3 2024 May 14, 2025	BUY	$4.8 - $9.99 $206,894 - $430,598	43,103 Added 66.21%	108,201 $1.01 Million

Q3 2024 Nov 14, 2024	BUY	$4.8 - $9.99 $206,894 - $430,598	43,103 Added 66.21%	108,201 $1.01 Million
Q2 2024 May 14, 2025	SELL	$5.05 - $8.0 $163,857 - $259,576	-32,447 Reduced 33.26%	65,098 $374,000
Q2 2024 Oct 17, 2024	SELL	$5.05 - $8.0 $49,853 - $78,976	-9,872 Reduced 13.17%	65,098 $374,000
Q2 2024 Aug 14, 2024	SELL	$5.05 - $8.0 $49,853 - $78,976	-9,872 Reduced 13.17%	65,098 $374,000
Q1 2024 Oct 17, 2024	BUY	$2.82 - $7.94 $27,839 - $78,383	9,872 Added 15.16%	74,970 $503,000
Q1 2024 Aug 16, 2024	SELL	$2.82 - $7.94 $85,003 - $239,335	-30,143 Reduced 28.68%	74,970 $503,000
Q1 2024 May 15, 2024	SELL	$2.82 - $7.94 $85,003 - $239,335	-30,143 Reduced 28.68%	74,970 $503,000
Q4 2023 Aug 16, 2024	BUY	$2.94 - $6.76 $117,644 - $270,501	40,015 Added 61.47%	105,113 $677,000
Q4 2023 Feb 13, 2024	BUY	$2.94 - $6.76 $96,626 - $222,174	32,866 Added 45.49%	105,113 $677,000
Q3 2023 Nov 15, 2023	SELL	$5.0 - $9.87 $80,605 - $159,114	-16,121 Reduced 18.24%	72,247 $361,000
Q2 2023 Aug 14, 2023	SELL	$5.37 - $8.84 $27,918 - $45,959	-5,199 Reduced 5.56%	88,368 $622,000
Q1 2023 May 15, 2023	SELL	$4.66 - $8.99 $969,275 - $1.87 Million	-207,999 Reduced 68.97%	93,567 $580,000
Q4 2022 Feb 14, 2023	SELL	$5.44 - $9.46 $4 Million - $6.95 Million	-734,549 Reduced 70.89%	301,566 $1.92 Million
Q3 2022 Nov 14, 2022	SELL	$7.52 - $18.01 $1.39 Million - $3.34 Million	-185,347 Reduced 15.17%	1,036,115 $8.89 Million
Q2 2022 Oct 27, 2022	BUY	$8.48 - $16.84 $1.63 Million - $3.25 Million	192,736 Added 18.74%	1,221,462 $16.6 Million
Q2 2022 Aug 15, 2022	BUY	$8.48 - $16.84 $1.63 Million - $3.25 Million	192,736 Added 18.74%	1,221,462 $16.6 Million
Q1 2022 Oct 27, 2022	SELL	$8.87 - $22.1 $1.71 Million - $4.26 Million	-192,736 Reduced 15.78%	1,028,726 $15.7 Million
Q1 2022 May 13, 2022	BUY	$8.87 - $22.1 $4.23 Million - $10.5 Million	476,821 Added 86.4%	1,028,726 $15.7 Million
Q4 2021 Feb 14, 2022	SELL	$10.79 - $22.87 $4.61 Million - $9.77 Million	-427,322 Reduced 43.64%	551,905 $12.6 Million
Q3 2021 Nov 15, 2021	BUY	$8.33 - $15.02 $8.16 Million - $14.7 Million	979,227 New	979,227 $13.6 Million

Others Institutions Holding FHTX

# of Institutions

Shares Held

37M

Call Options Held

100

Put Options Held

View Full List

About Foghorn Therapeutics Inc.

Ticker FHTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,637,400
Market Cap $195M
Description
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...

More about FHTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account